Author: Aparna AbbaRaju

Metachromatic Leukodystrophy
FDA Approves Lenmeldy Medicine to Treat Children with Metachromatic Leukodystrophy

The FDA approved Lenmeldy (atidarsagene autotemcel) today, making it the first FDA-approved gene therapy for.

A New Treatment for Lymphomas Targets drug-resistant Pathway

Patients with certain form of lymphomas who have become resistant to regular therapies may benefit.

FDA Approves Rezdiffra Drug to Treat Liver Disease

Rezdiffra (resmetirom) was approved today by the United States Food and Drug Administration for the.

Effects of the COVID-19 Pandemic on responses to Therapy for Anxiety

The commencement of the COVID-19 pandemic resulted in unparalleled exposure to stresses caused by worries.

preterm birth in pregnant women
Progesterone Provides Protection Against Premature Birth for Infants

Women with a short cervix around 20 weeks of pregnancy are at a higher risk.

cardiovascular diseases
PFAS in Blood Linked to Cardiovascular Risk

According to estimates, over 10,000 distinct per- and polyfluorinated alkyl compounds (PFAS) have been created.

Obesity or Overweight
FDA Approves Wegovy injection to Lower risk of heart attack in Obese patients

The FDA has approved a new indication for Wegovy (semaglutide) injection to lower the risk.

mental health of children with epilepsy
New Psychological Treatment for Children with Epilepsy

A new psychological treatment for children with epilepsy created by a UCL-led team of scientists.

Type 2 diabetes
Role of Genetic Clusters and Biological Pathways in Type 2 Diabetes

Numerous biological factors influence the development and progression of type 2 diabetes, including the body’s.

Menopause impacts mental health
Study finds Menopause does not Always Affect Mental Health

A new research report from Brigham and Women’s Hospital and collaborators suggests that menopause does.